Related references
Note: Only part of the references are listed.Maternal age affects the relationship of basal FSH and anti-Mullerian hormone concentrations with post-ICSI/IVF live birth
Jose Buratini et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2021)
Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis
Nathalie Sermondade et al.
HUMAN REPRODUCTION UPDATE (2019)
Management of Women With an Unexpected Low Ovarian Response to Gonadotropin
Alessandro Conforti et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
The Effect of Dose Adjustments in a Subsequent Cycle of Women With Suboptimal Response Following Conventional Ovarian Stimulation
Panagiotis Drakopoulos et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta- analysis accounting for patient type
C. B. Lambalk et al.
HUMAN REPRODUCTION UPDATE (2017)
Cumulative live birth rate: time for a consensus?
Abha Maheshwari et al.
HUMAN REPRODUCTION (2015)
Sub-optimal responders following controlled ovarian stimulation: an overlooked group?
N. P. Polyzos et al.
HUMAN REPRODUCTION (2015)
The evaluation of recombinant LH supplementation in patients with suboptimal response to recombinant FSH undergoing IVF treatment with GnRH agonist down-regulation
Fatma Yazici Yilmaz et al.
GYNECOLOGICAL ENDOCRINOLOGY (2015)
Change in oocyte yield in repeated in vitro fertilization cycles: effect of ovarian reserve
Erin E. Eppsteiner et al.
FERTILITY AND STERILITY (2014)
Improving the Reporting of Clinical Trials of Infertility Treatments (IMPRINT): modifying the CONSORT statement
Richard S. Legro et al.
HUMAN REPRODUCTION (2014)
Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice
Antonio La Marca et al.
HUMAN REPRODUCTION UPDATE (2014)
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
A. P. Ferraretti et al.
HUMAN REPRODUCTION (2011)
Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis
M. D. Sterrenburg et al.
HUMAN REPRODUCTION UPDATE (2011)
A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count
K. Jayaprakasan et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2010)
The science behind 25 years of ovarian stimulation for in vitro fertilization
NS Macklon et al.
ENDOCRINE REVIEWS (2006)
Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial
G De Placido et al.
HUMAN REPRODUCTION (2005)
Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques
AP Ferraretti et al.
FERTILITY AND STERILITY (2004)
Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration
M Filicori et al.
HUMAN REPRODUCTION (2002)
Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH
G De Placido et al.
HUMAN REPRODUCTION (2001)
Dose-finding study for the use of long-acting gonadotrophin-releasing hormone analogues prior to ovarian stimulation for IVF
SF Yim et al.
HUMAN REPRODUCTION (2001)
Defining and predicting the poor responder!
A Gorgy et al.
FERTILITY AND STERILITY (2001)
The role of LH in ovarian stimulation -: Exogenous LH:: let's design the future
DP Lévy et al.
HUMAN REPRODUCTION (2000)